{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"Hereditary Oncology Testing: Wei Shen, Ph.D.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/226f6f3e\"></iframe>","width":"100%","height":180,"duration":642,"description":"Wei Shen, Ph.D., discusses Mayo Clinic Laboratories’ new hereditary oncology panels, which use next-generation sequencing to identify germline alterations associated with increased cancer risk. Curated through a rigorous selection framework developed by Mayo Clinic oncology experts, the panels include only clinically significant genes to provide clarity on diagnosis, prognosis, and treatment approaches for individuals at risk for hereditary cancers. ","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}